Yuji Uehara, M., Hiroki Izumi, M., Tetsuro Taki, M., Tetsuya Sakai, M., Hibiki Udagawa, M., Eri Sugiyama, M., . . . Genichiro Ishii, M. Solid Predominant Histology and High Podoplanin Expression in Cancer-Associated Fibroblast Predict Primary Resistance to Osimertinib in EGFR-Mutated Lung Adenocarcinoma. Elsevier.
Chicago Style (17th ed.) CitationYuji Uehara, MD, et al. Solid Predominant Histology and High Podoplanin Expression in Cancer-Associated Fibroblast Predict Primary Resistance to Osimertinib in EGFR-Mutated Lung Adenocarcinoma. Elsevier.
MLA (9th ed.) CitationYuji Uehara, MD, et al. Solid Predominant Histology and High Podoplanin Expression in Cancer-Associated Fibroblast Predict Primary Resistance to Osimertinib in EGFR-Mutated Lung Adenocarcinoma. Elsevier.